Guardant Health
GH
#2452
Rank
โ‚ฌ4.87 B
Marketcap
39,46ย โ‚ฌ
Share price
-0.46%
Change (1 day)
151.97%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -4,68ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -4,31ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,62ย โ‚ฌ a decrease over its 2021 EPS that were of -3,51ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,68ย โ‚ฌ-16.6%
2022-5,62ย โ‚ฌ60%
2021-3,51ย โ‚ฌ55.04%
2020-2,26ย โ‚ฌ207.14%
2019-0,74ย โ‚ฌ-19.81%
2018-0,92ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-4,23ย โ‚ฌ-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,10ย โ‚ฌ-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA